LAKE REGION HEALTHCARE
1. Target Overview & Investment Thesis
LAKE REGION HEALTHCARE is a 80-bed under-performing / distressed in OTTER TAIL, MN with $134.1M in net patient revenue and a -11.4% operating margin. The hospital serves a payer mix of 33.6% Medicare, 2.6% Medicaid, and 63.7% commercial.
Thesis: Turnaround. Our ML models identify $9.9M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -11.4% to -4.1% (+736bps).
| Net Revenue HCRIS | $134.1M |
| Current EBITDA COMPUTED | $-15.3M |
| Operating Margin COMPUTED | -11.4% |
| Occupancy HCRIS | 18.8% |
| Revenue / Bed COMPUTED | $1.7M |
| Net-to-Gross HCRIS | 39.5% |
| Distress Probability ML | 55.5% |
2. Market Context & Competitive Position
MN has 141 Medicare-certified hospitals with a median operating margin of -3.6%. The target's margin of -11.4% places it below the state median. Among 22 size-comparable peers (40-160 beds), the median margin is -6.3%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (40-160), prioritizing same-state peers. 22 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| LAKE REGION HEALTHCARE (Target) | MN | 80 | $134.1M | -11.4% |
| SMDC MEDICAL CENTER | MN | 118 | $519.2M | -7.1% |
| MCHS - SOUTHWEST MINNESOTA REG | MN | 118 | $473.6M | -9.8% |
| LAKEVIEW MEMORIAL | MN | 68 | $411.9M | 60.9% |
| SANFORD BEMIDJI | MN | 94 | $312.6M | -19.6% |
| RIDGEVIEW MEDICAL CENTER | MN | 109 | $287.8M | -14.2% |
| ST. JOSEPHS MEDICAL CENTER | MN | 127 | $283.3M | -0.0% |
| MAYO CLNIC HLTH SYS-ALBRT LEA | MN | 79 | $271.9M | -16.6% |
| GILLETTE CHILDRENS SPECIALTY H | MN | 60 | $266.7M | -6.3% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $9.9M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $2.8M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $2.7M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $2.7M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $1.6M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $86K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-15.3M |
| + RCM Uplift | +$9.9M |
| Pro Forma EBITDA | $-5.4M |
| Current Margin | -11.4% |
| Pro Forma Margin | -4.1% |
| WC Released (1x) | $5.1M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-23.5M | $-2.3M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-23.5M | $-10.1M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-21.2M | $14.8M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-21.2M | $9.9M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-25.9M | $-44.0M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-25.9M | $-56.8M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| Medium | Low occupancy | At 18.8%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case |
| High | Elevated distress probability | Model estimates 55.5% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 22 hospitals with 40-160 beds
- Same-state prioritization (n=23)
- Comp margins: P25=-10.3% / P50=-6.3% / P75=-0.8%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.